<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Problems of Virology</journal-id><journal-title-group><journal-title xml:lang="en">Problems of Virology</journal-title><trans-title-group xml:lang="ru"><trans-title>Вопросы вирусологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0507-4088</issn><issn publication-format="electronic">2411-2097</issn><publisher><publisher-name xml:lang="en">Central Research Institute for Epidemiology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">12037</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Inhibition of herpes simplex virus type 1 reproduction by probiotic bacteria in vitro</article-title><trans-title-group xml:lang="ru"><trans-title>Угнетение репродукции вируса простого герпеса 1-го типа пробиотическими бактериями в системе in vitro</trans-title></trans-title-group></title-group><pub-date date-type="pub" iso-8601-date="2010-08-15" publication-format="electronic"><day>15</day><month>08</month><year>2010</year></pub-date><volume>55</volume><issue>4</issue><issue-title xml:lang="en">NO4 (2010)</issue-title><issue-title xml:lang="ru">№4 (2010)</issue-title><fpage>13</fpage><lpage>15</lpage><history><date date-type="received" iso-8601-date="2023-06-09"><day>09</day><month>06</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2010, Ermolenko E.I., Furaeva V.A., Isakov V.A., Ermolenko E.I., Suvorov A.N., Yermolenko E.I., Furaeva V.A., Isakov V.A., Yermolenko D.K., Suvorov A.N.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2010, Ермоленко Е.И., Фураева В.А., Исаков В.А., Ермоленко Е.И., Суворов А.Н., Yermolenko E.I., Furaeva V.A., Isakov V.A., Yermolenko D.K., Suvorov A.N.</copyright-statement><copyright-year>2010</copyright-year><copyright-holder xml:lang="en">Ermolenko E.I., Furaeva V.A., Isakov V.A., Ermolenko E.I., Suvorov A.N., Yermolenko E.I., Furaeva V.A., Isakov V.A., Yermolenko D.K., Suvorov A.N.</copyright-holder><copyright-holder xml:lang="ru">Ермоленко Е.И., Фураева В.А., Исаков В.А., Ермоленко Е.И., Суворов А.Н., Yermolenko E.I., Furaeva V.A., Isakov V.A., Yermolenko D.K., Suvorov A.N.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://virusjour.crie.ru/jour/article/view/12037">https://virusjour.crie.ru/jour/article/view/12037</self-uri><abstract xml:lang="en"><p>Light and immunofluorescence microscopies were used to study the cytopathic effect of herpes simplex virus type 1 (HSV-1) grown on the Vero cell cultures in the absence or presence of supernatants of Enterococcus faecium L3, Lactobacillus plantarum 8A-P3, and Escherichia coli M17. The effect of the probiotic strains was evaluated estimating the proportion of changed cells and the infective dose of the virus. The supernatants of the cultures of Lactobacillus sp. and Enterococcus sp., unlike those of E. coli, have antiviral activity. Inhibited viral replication was more evident when the supernatants were added until the cultured HSV-1 cells were infective. An enterococcal supernatant and its obtained peptide extract showed the maximum antiviral activity. This strain may be associated with the production of bacteriocins and bacteriocin-like substances.</p></abstract><trans-abstract xml:lang="ru"><p>Цитопатическое действие вирусов простого герпеса 1-го типа (ВПГ-1), культивирующихся на культуре клеток Vero без какого-либо воздействия или в присутствии супернатантов штаммов Enterococcus faecium L3, Lactobacillus plantarum 8A-P3 и Escherichia coli M17, было исследовано при помощи световой и иммунофлюоресцентной микроскопии. Влияние пробиотических штаммов оценивали, определяя процент измененных клеток и инфекционную дозу вируса. Супернатанты культур Lactobacillus sp. и Enterococcus sp. в отличие от E. coli обладали антивирусной активностью. Ингибирование репродукции вируса было выражено в большей степени при добавлении супернатантов до инфицирования культуры клеток ВПГ-1. Максимальную антивирусную активность проявили супернатант энтерококков и полученный из него пептидный экстракт. Это может быть связано с продукцией этим штаммом бактериоцинов и бактериоциноподобных субстанций.</p></trans-abstract><kwd-group xml:lang="en"><kwd>herpes simplex virus</kwd><kwd>cytopathic effect</kwd><kwd>lactobacilli</kwd><kwd>enterococci</kwd><kwd>bacteriocins</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>вирус простого герпеса</kwd><kwd>цитопатический эффект</kwd><kwd>лактобациллы</kwd><kwd>энтерококки</kwd><kwd>бактериоцины</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Баринский И. Ф., Чешик С. Г. Инфекции, вызванные вирусами человека простого герпеса 1-го и 2-го типов // Медицинская вирусология: Руководство / Под ред. Д. К. Львова. - М., 2008. - С. 412-432.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Ермоленко Е. И., Черныш А. Ю., Берлов М. Н. и др. Антагонистическая активность энтерококков в отношении Streptococcus pyogenes // Вестн. Санкт-Петербургского ун-та. - 2008. - № 1. - С. 18-25.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Banasaz M., Norin E., Holma R., Midtved T. Increased enterocite production in gnotobiotic rats monoassociated with Lactobacillus rhamnosus GG // Appl. Environ. Microbiol. - 2002. - Vol. 68. - P. 3031-3034.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Cinatl J. J., Cinatl J., Rabenau H., Gumbel H. et al. In vitro anti-human immunodeficiency activity of 2',3'-dideoxynucleotides and their effect on clonal growth of hemopoietic cells from human bone marrow // Arzneimittelforschung. - 1993. - Bd 43, N 5. - S. 622-625.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Daher K., Selsted M. E., Lehrer R. I. Direct inactivation of viruses by human granulocyte defensins // J. Virol. - 1986. - Vol. 60. - P. 1068-1074.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Hampl H., Schlehofer J. R., Habermehl K. O. Differences in the morphology of herpes simplex virus infected cells. II Type specific virus membrane alterations of HSV-1 and HSV-2 infected cells // Med. Microbiol. Immunol. - 1981. - Vol. 169, N 3. - P. 209-223.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Kaila M., Isolauri E., Arvilommmi H., Vesikari T. Viable versus inactivated Lactobacillus strain GG in acute rotavirus diarrhea // Arch. Dis. Childh. - 1995. - Vol. 72, N 1. - P. 43-51.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Klebanoff S. J., Belding M. E. Virucidal activity of H2O2-generating bacteria: requirement for peroxidase and a halide // J. Infect. Dis. - 1974. - Vol. 129, N 3. - P. 345-348.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Klebanoff S. J., Coombs R. W. Virucidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heteroxesual transmission // J. Exp. Med. - 1991. - Vol. 174. - P. 289-292.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Klebanoff S., Watts D. H., Mehlin C., Headley C. M. Lactobacilli and vaginal host defense: activation of the human immunodeficiency virus type 1 long terminal repeat, cytokine production, a NF-kB // J. Infect. Dis. - 1999. - Vol. 179. - P. 653-660.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Lehrer R. I., Daher K., Ganz T., Selsted M. E. Direct inactivation of viruses by MCP-1 and MCP-2, natural peptide antibiotics from rabbit leucocytes // J. Virol. - 1985. - Vol. 54. - N 2. - P. 467-472.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Majamaa H., Isolauri E., Saxelin M., Vesikari T. Lactic acid bacteria in the treatment of cute rotavirus gastroenteritis // J. Pediatr. Gastroenterol. Nutr. - 1995. - Vol. 20, N 3. - P. 333-338.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Ohashi T., Minamishima Y., Yokokura T., Mutai M. Induction of resistance in mice against murine cytomegalovirus by cellular components of Lactobacillus casei // Biotherapy. - 1989. - Vol. 1, N 2. - P. 89-95.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Rosenthal K. S., Killius J., Hodnichak C. M. et al. Mild acidic pH inhibition of the major pathway of herpes simplex virus entry into HEp-2 cells // J. Gen. Virol. - 1989. - Vol. 70, N 4. - P. 857-867.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Klebanoff S. J., Watts D. H., Mehlin C., Headley C. M. Lactobacillus and vaginal host defense: activation of the human immunodeficiency virus type 1 long terminal repeat, cytokine production, and NF-kB // J. Infect. Dis. - 1999. - Vol. 179. - P. 653-660.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Yasin B., Wang W., Pang M. et al. Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry // J. Virol. - 2004. - Vol. 78, N 10. - P. 5147-5156.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Yasui H., Kiyoshima J., Hori T., Shida K. Protection against influenza virus infection of mice fed Bifidobacterium breve YIT4064 // Clin. Diagn. Lab. Immunol. - 1999. - Vol. 6, N 2. - P. 186-192.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Waschmann M. B., Farias M. E., Takeda E., Sesma F. et al. Antiviral activity of enterocin CRL35 aginst herpes viruses // J. Antimicrob. Agents. - 1999. - Vol. 12. - P. 293-299.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Waschmann M. B., Castilla V., Holgado A. P. et al. Enterocin CRL35 inhibits late stages of HSV-1 and HSV-2 replication // Antiviral Res. - 2003. - Vol. 58, N 1. - P. 17-24.</mixed-citation></ref></ref-list></back></article>
